Acesso livre
Acesso livre

Geriatria

Revisão | Recuperação física subótima após doença crítica.

6 Out, 2022 | 12:29h

Poor physical recovery after critical illness: incidence, features, risk factors, pathophysiology, and evidence-based therapies – Current Opinion in Critical Care

 


Estudo de coorte | Diabetes diagnosticado em adultos mais jovens está associado com morbidade aumentada em comparação ao diagnóstico feito em adultos mais velhos.

4 Out, 2022 | 12:39h

Associations of Age at Diagnosis and Duration of Diabetes With Morbidity and Mortality Among Older Adults – JAMA Network Open

 


Revisão | Diagnóstico e tratamento de síndromes mielodisplásicas.

8 Set, 2022 | 14:17h

Diagnosis and Treatment of Myelodysplastic Syndromes: A Review – JAMA (gratuito por tempo limitado)

Revisão clínica em áudio: Diagnosis and Management of Myelodysplastic Syndromes – JAMA

 


Atualização sobre o tratamento do diabetes em instituições de longa permanência.

29 Ago, 2022 | 17:49h

Update on the management of diabetes in long-term care facilities – BMJ Open Diabetes Research & Care

 


Revisão de escopo de estudos randomizados sobre descontinuação de medicamentos em idosos.

29 Ago, 2022 | 17:42h

Scoping Review of Randomized Trials With Discontinuation of Medicines in Older Adults – JAMDA

 


Revisão sistemática | Carga anticolinérgica para predição de declínio cognitivo ou sintomas neuropsiquiátricos em idosos com comprometimento cognitivo leve ou demência.

29 Ago, 2022 | 16:33h

Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia – Cochrane Library

Resumo: The impact of cumulative medications with anticholinergic effects on future adverse clinical outcomes in people with dementia – Cochrane Library

Conteúdos relacionados:

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models – Drugs & Aging

Commonly-prescribed drugs and dementia: should we be worried? – Evidently Cochrane

Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome – Cochrane Library

Anticholinergic drugs and dementia: time for transparency in the face of uncertainty – Cochrane Library

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study – JAMA Internal Medicine

How well do you know your anticholinergic (antimuscarinic) drugs? – Therapeutics Initiative

Anticholinergic drugs and risk of dementia: case-control study – The BMJ

 


Revisão | “Enhanced recovery” neurocirúrgica de pacientes geriátricos submetidos a craniotomia eletiva.

23 Ago, 2022 | 16:56h

Neurosurgical enhanced recovery after surgery ERAS for geriatric patients undergoing elective craniotomy: A review – Medicine

Conteúdos relacionados:

Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines

Top 100 Most-Cited Articles on Enhanced Recovery After Surgery: A Bibliometric Analysis and Visualized Study – Frontiers in Surgery

 


Lançamento do primeiro posicionamento científico da OMS sobre melhora da saúde cerebral ao longo da vida.

22 Ago, 2022 | 16:18h

Comunicado de imprensa: Launch of first WHO position paper on optimizing brain health across life – World Health Organization

Posicionamento científico da OMS: Optimizing brain health across the life course – World Health Organization

 

Comentário no Twitter (fio – clique para saber mais)

 


Falando sobre morrer: conversas melhores no fim da vida.

22 Ago, 2022 | 15:57h

Talking about dying: better conversations at the end of life – Evidently Cochrane

Revisões originais:

Interventions for interpersonal communication about end of life care between health practitioners and affected people – Cochrane Library

Communicating with patients and families about illness progression and end of life: a review of studies using direct observation of clinical practice – BMC Palliative Care

 

Comentário no Twitter

 


Estudo sugere que os sintomas da Covid longa afetem 1 em cada 8 pacientes.

22 Ago, 2022 | 14:59h

Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study – The Lancet

Comunicado de imprensa: Most reliable estimates to date suggest one in eight COVID-19 patients develop long COVID symptoms – Lancet

Comentários:

Long COVID symptoms affect 1 in 8 adults, some for 2 years – CIDRAP

Covid-19: One in eight adults develops long covid symptoms, study suggests – The BMJ

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.